CA3937043097 - Common Stock
GREENBROOK TMS INC
NASDAQ:GBNH (2/23/2024, 7:00:01 PM)
After market: 0.1153 -0.01 (-4.71%)0.121
-0.08 (-40.69%)
Greenbrook Tms, Inc. engages in the control and operation of a network of outpatient mental health services centers that specialize in the provision of Transcranial Magnetic Stimulation (TMS) therapy and other treatment modalities for the treatment of depression and related psychiatric services. The company is headquartered in Toronto, Ontario and currently employs 629 full-time employees. The company went IPO on 2018-11-27. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The firm operates a network of outpatient mental health service centers that specialize in Treatment across the United States. The company offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The firm owns and operates 133 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, and South Carolina.
GREENBROOK TMS INC
890 Yonge St 7th Floor
TORONTO ONTARIO M4W 3P4
P: 14163229700
CEO: Bill Leonard
Employees: 629
Website: https://www.greenbrooktms.com/
Greenbrook TMS has received a final delisting notice from Nasdaq, with trading of its common shares set to be suspended on February 26, 2024.
/CNW/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing...
/PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing...
/CNW/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company"), today announced that it has entered into securities purchase agreements with...
Pre-market stock movers are a hot topic on Thursday and we're starting the day with a breakdown of all the latest news this morning!
Shares of NeoGenomics, Inc. (NASDAQ: NEO) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS guidance above estimates.
Here you can normally see the latest stock twits on GBNH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: